1. Scrip
  2. >>Business

Ease The Pain – Making Payment Models, Tech, Integration Work For Patients

Roche Could Consider Differential Pricing For Pooled Purchases

 
• By Vibha Ravi

Multiple payment models, including differential pricing for pooled purchases, and technology-based healthcare platforms are some of the ways to build a patient-centric ecosystem said officials from Roche, VCs and non-government bodies at a recent conference

Concept of integrated healthcare
Integrated Healthcare Approaches Are The Need Of The Hour • Source: Shutterstock

While a ‘patient-centric’ approach makes for good sound bites, it takes a lot of thought and effort to make it work in real life. Done right, the methodology could substantially ease the lives of caregivers and of patients with chronic diseases like cancer.

At the recent BioAsia conference, two panels discussed, among other topics, how integrated healthcare, multiple payment models and access mechanisms...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Sanofi’s Wayrilz Gets Out Of The Blocks With First US Approval For ITP

 
• By Alexandra Shimmings

The FDA go-ahead makes it the first for a BTK inhibitor in immune thrombocytopenia. Sanofi hopes it will mark the start of a number of indications for rilzabrutinib.

Alnylam Pairs Zilebesiran With Diuretics After Phase II Endpoint Miss In Hypertension

 
• By Manas Mishra

Alnylam and Roche refine zilebesiran’s Phase III trial design after a Phase II miss, focusing on patients on diuretics.

Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: Lilly’s orforglipron strong in diabetic obesity; Ascletis confident in oral GLP-1 challenger; myostatin drugs progress for obesity; an interview with OneSource’s CEO; and an analysis of Dupixent’s pipeline-in-a-product success.